Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOOTNEUROTOX: Tibial Nerve Selective Neurotomy vs Botulinum Toxin for Spastic Foot
NCT05874154Recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2024
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Goal Attainment Scaling at 14 months. Started Jan 2024; status: recruiting.
Beyond the preview
Go deeper on NCT05874154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05874154.